Want to see IN:NIVABUPA full AI Analyst Report?
NIVABUPA Stock Chart & Stats
₹86.62
₹0.28(0.32%)
At close: 4:00 PM EDT
₹86.62
₹0.28(0.32%)
Day’s Range― - ―
52-Week Range₹67.50 - ₹91.39
Previous CloseN/A
Volume408.56K
Average Volume (3M)100.36K
Market Cap
₹152.69B
Enterprise Value₹157.33K
Total Cash (Recent Filing)₹883.00M
Total Debt (Recent Filing)₹2.50B
Price to Earnings (P/E)42.2
Beta0.87
Next Earnings
Nov 30, 2026EPS Estimate
0.54Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.94
Shares Outstanding1,849,233,600
10 Day Avg. Volume100,838
30 Day Avg. Volume100,362
Financial Highlights & Ratios
PEG Ratio-2.44
Price to Book (P/B)4.17
Price to Sales (P/S)1.99
P/FCF Ratio15.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹102.50Price Target Upside18.33% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)2.48
Revenue Forecast (FY)₹92.93B
Bulls Say, Bears Say
Bulls Say
Strong Revenue ExpansionRapid premium growth and improved gross profitability indicate strong demand and expanding scale. If sustained, greater volume can spread fixed operating costs and strengthen the company’s competitive position in health insurance.
Conservative LeverageVery low leverage reduces balance-sheet risk and limits interest-related pressure on earnings. This gives the insurer greater financial flexibility to support underwriting growth, absorb claims volatility, and invest in distribution.
Positive Free Cash FlowPositive operating and free cash flow, with free cash flow close to reported earnings, indicates reasonable earnings quality and internal funding capacity. This supports ongoing operations and reduces reliance on external capital.
Bears Say
Margin CompressionSharp operating and net margin declines suggest that costs, claims, pricing, or acquisition expenses are absorbing more of the revenue increase. Persistent compression would weaken the benefits of scale and constrain profitability.
Falling Cash GenerationAlthough cash flow remains positive, the year-over-year reduction signals weaker conversion of business growth into deployable cash. Continued deterioration could limit investment in distribution, technology, and customer service.
Low Returns On EquityLow and declining returns on equity indicate that the company is generating modest earnings from its capital base. Combined with reduced equity, this points to weaker capital efficiency and could limit sustainable shareholder returns.
Niva Bupa Health Insurance Company Limited News
NIVABUPA FAQ
What was Niva Bupa Health Insurance Company Limited’s price range in the past 12 months?
Niva Bupa Health Insurance Company Limited lowest stock price was ₹67.50 and its highest was ₹91.39 in the past 12 months.
What is Niva Bupa Health Insurance Company Limited’s market cap?
Niva Bupa Health Insurance Company Limited’s market cap is ₹152.69B.
When is Niva Bupa Health Insurance Company Limited’s upcoming earnings report date?
Niva Bupa Health Insurance Company Limited’s upcoming earnings report date is Nov 30, 2026 which is in 97 days.
How were Niva Bupa Health Insurance Company Limited’s earnings last quarter?
Niva Bupa Health Insurance Company Limited released its earnings results on Jul 30, 2026. The company reported ₹0.72 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Niva Bupa Health Insurance Company Limited overvalued?
According to Wall Street analysts Niva Bupa Health Insurance Company Limited’s price is currently Undervalued.
Does Niva Bupa Health Insurance Company Limited pay dividends?
Niva Bupa Health Insurance Company Limited does not currently pay dividends.
What is Niva Bupa Health Insurance Company Limited’s EPS estimate?
Niva Bupa Health Insurance Company Limited’s EPS estimate is 0.54.
How many shares outstanding does Niva Bupa Health Insurance Company Limited have?
Niva Bupa Health Insurance Company Limited has 1,849,233,600 shares outstanding.
What happened to Niva Bupa Health Insurance Company Limited’s price movement after its last earnings report?
Niva Bupa Health Insurance Company Limited reported an EPS of ₹0.72 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.07%.
Which hedge fund is a major shareholder of Niva Bupa Health Insurance Company Limited?
Currently, no hedge funds are holding shares in IN:NIVABUPA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Niva Bupa Health Insurance Company Limited
Niva Bupa Health Insurance Company Limited provides health insurance products in India. It offers health insurance plans, such as individual, family, NRIs, senior citizens, personal accident, critical illness; travel insurance, including international and studying abroad insurance plans; and corporate insurance comprising group and start up health, group personal accident and OPD coverage, and group health insurance claim process. The company was formerly known as Max Bupa Health Insurance Company Limited and changed its name to Niva Bupa Health Insurance Company Limited in July 2021. The company was founded in 1947 and is based in Gurugram, India. Niva Bupa Health Insurance Company Limited is a subsidiary of Bupa Singapore Holdings Pte. Ltd.
NIVABUPA Stock 12 Month Forecast
Average Price Target
₹102.50
▲(18.33% Upside)
Technical Analysis
HDFC Life Insurance Co. Ltd.
―
ICICI Prudential Life Insurance Co. Ltd.
―
Max Financial Services Limited
―
SBI Life Insurance Co. Ltd.
―
Star Health & Allied Insurance Co. Ltd.
―








